Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Breast/Ovarian Cancer (brca1, brca2)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01333748
What this trial is testing

Search Allelic Imbalance of Expression of BRCA Genes in Hereditary Risk of Breast and/or Ovarian Cancer

Who this might be right for
Hereditary Breast and Ovarian Cancer Syndrome
Centre Francois Baclesse 530
Not applicableActive Not RecruitingNCT02760849
What this trial is testing

Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations

Who this might be right for
Deleterious BARD1 Gene MutationDeleterious BRCA1 Gene MutationDeleterious BRCA2 Gene Mutation+11 more
M.D. Anderson Cancer Center 374
Not applicableActive Not RecruitingNCT01230346
What this trial is testing

Culturally-Informed Counseling in Latinas at High Risk for Hereditary Breast or Ovarian Cancer

Who this might be right for
No Evidence of DiseaseBRCA1 SyndromeBRCA2 Syndrome+2 more
City of Hope Medical Center 493
Not applicableEnded earlyNCT01374685
What this trial is testing

Family Communication of Hereditary Breast and Ovarian Cancer Risk Among African Americans

Who this might be right for
Ovarian NeoplasmCancer GeneticsBreast Cancer
National Human Genome Research Institute (NHGRI) 8
Not applicableStudy completedNCT02133703
What this trial is testing

Decision Support Following Genetic Testing for Breast-Ovarian Cancer Susceptibility

Who this might be right for
Breast CancerOvarian Cancer
Georgetown University 369
Not applicableStudy completedNCT03225170
What this trial is testing

Is it Feasible?: Self-Affirmation for Hereditary Breast and Ovarian Cancer Genetic Counseling

Who this might be right for
Breast Cancer
National Human Genome Research Institute (NHGRI) 64
Not applicableLooking for participantsNCT01689584
What this trial is testing

COsegregation of VARiants in Panel of Genes

Who this might be right for
Gene Mutation-Related CancerGenetic Predisposition
Institut Curie 11,000
Testing effectiveness (Phase 2)Study completedNCT00321633
What this trial is testing

Carboplatin or Docetaxel in Treating Women With Metastatic Genetic Breast Cancer

Who this might be right for
brca1 Mutation Carrierbrca2 Mutation CarrierBreast Cancer+1 more
University College London Hospitals 148
Not applicableStudy completedNCT00001468
What this trial is testing

Outcomes of Education and Counseling for BRCA1 Testing

Who this might be right for
Breast NeoplasmsOvarian Neoplasms
National Human Genome Research Institute (NHGRI) 1,500
Not applicableNot Yet RecruitingNCT07236359
What this trial is testing

Evaluation of Well Being and Patient Reported Outcomes After Robotic Single-port Nipple Sparing Mastectomy and Implant Reconstruction

Who this might be right for
Breast ReconstructionBreast CancerHereditary Breast/Ovarian Cancer (brca1, brca2)+1 more
Beaumont Hospital 108
Early research (Phase 1)Study completedNCT00535119
What this trial is testing

Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer

Who this might be right for
Adult Solid NeoplasmBRCA1 Mutation CarrierBRCA2 Mutation Carrier+1 more
National Cancer Institute (NCI) 107
Not applicableActive Not RecruitingNCT01608074
What this trial is testing

Radical Fimbriectomy for Young BRCA Mutation Carriers

Who this might be right for
BRCA1 MutationBRCA2 MutationHereditary Breast and Ovarian Cancer
Centre Oscar Lambret 123